Invacare — Investor Presentation (May 2022)
23 slides from Invacare's investor presentation, May 23, 2022
Slide 1: Invacare Corporation Investor Presentation
I N VA C A R E C O R P O R AT I O N Investor Presentation (NYSE: IVC) May 23, 2022
Slide 2: Forward Looking Statements
I N VA C A R E C O R P O R AT I O N Forward Looking Statements This presentation contains forward-looking statements within the meaning of the “Safe Harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are those that describe future outcomes or expec
Slide 3: Making Life's Experiences Possible
I N VA C A R E C O R P O R AT I O N Possible TM Experiences Making Life’s
Slide 4: About Us / What We Do
I N VA C A R E C O R P O R AT I O N ABOUT US WHAT WE DO Headquartered in Elyria, OH (outside of Cleveland), Invacare is a leading manufacturer and distributor in its Invacare is proudly celebrating over 40 years of providing markets for durable medical equipment used in non-acute clinically complex
Slide 5: Solutions Across The Continuum Of Care
Solutions Across The Continuum Of Care Providing essential clinical solutions for broad range of conditions I N VA C A R E C O R P O R AT I O N Solution Areas (24-Hours of Care) Move Rest Breathe Hygiene Custom power and manual Home care and long-term care Respiratory therapy products Safe patient h
Slide 6: Reported Net Sales: Broad Product Line with High Clinical Value
Reported Net Sales * Broad Product Line with High Clinical Value I N VA C A R E C O R P O R AT I O N $450 $409 $877 $400 Million* Lifestyle $350 $343 Globally focused on home healthcare and post-acute care, including aids for daily living, walking aids, patient lifts, $300 wheelchairs, beds and slee
Slide 7: Broad Global Presence
I N VA C A R E C O R P O R AT I O N Broad Global Presence $340M* $32M* $504M* Europe (57%)* North America (39%)* Asia Pacific (4%)* Primarily single payor reimbursement Primarily sell to durable medical Primarily target western-based systems which appreciate durable equipment providers, equipment fl
Slide 8: Transformation Plan Highlights
I N VA C A R E C O R P O R AT I O N Transformation Plan Highlights Invacare Corporation Presentation – May 23, 2022
Slide 9: Transformation Overview and History
Transformation Overview and History Since 2017, Invacare has made significant improvement in the financial performance of the business, which has been impacted by several external factors. As a result, the company implemented restructuring actions which delivered I N VA C A R E C O R P O R AT I O N
Slide 10: Transformation Accomplishments Since 2017
Transformation Accomplishments Since 2017 Area Accomplishment I N VA C A R E C O R P O R AT I O N Management Diversified and refreshed Board of Directors with approximately 60% of independent directors with less than 5-year tenure as of Annual Meeting in May 2022 Hired CIO to drive modernization of
Slide 11: Initiatives Accelerating Our Multi-Year Strategy to Return to Profitability
I N VA C A R E C O R P O R AT I O N Initiatives Accelerating Our Multi-Year Strategy to Return to Profitability Award winning clinical solutions and full product pipeline: ✓ Launched standing power positioning system for center-, front- and rear-wheel drive power wheelchairs with clinical and social
Slide 12: Innovation Pipeline
Innovation Pipeline Rehab (Mobility and Seating) Supporting sales growth with frequent introduction of clinically innovative solutions Post Acute Care (Lifestyle) Respiratory I N VA C A R E C O R P O R AT I O N Jan Ampla bariatric manual chair May Mar Jul Aug SMOOV AVIVA® FX / Clematis Pro AVIVA One
Slide 13: Track Record of Optimization
Track Record of Optimization Aligning footprint with new commercial strategy and sales level I N VA C A R E C O R P O R AT I O N Jan 31 Kirkland, Ontario manufacturing facility closure; Jan 31 Headcount Headcount reduction reduction Apr 30 Dec May Atlanta DC Completed NA Closure German headcount 2Q1
Slide 14: Actions Driving Sequential Improvement in Adjusted EBITDA
Actions Driving Sequential Improvement in Adjusted EBITDA Anticipated sequential I N VA C A R E C O R P O R AT I O N improvement in full year 2022 Expected benefit in 2022 from strategic actions taken Adjusted EBITDA compared to 1Q22 driven by: ➢ Benefit from Restructuring – streamline and simplify
Slide 15: Business Improvement Highlights
I N VA C A R E C O R P O R AT I O N Business Improvement Highlights Striving to regain market leadership A clear roadmap to further enhance and simplify operations Key Takeaways Strong pipeline of innovative products coming to market Financial performance improving as a result of these initiatives I
Slide 16: Our Products
I N VA C A R E C O R P O R AT I O N Our Products Invacare Corporation Presentation – May 23, 2022
Slide 17: Mobility & Seating – Custom Power and Manual
I N VA C A R E C O R P O R AT I O N Mobility & Seating – Custom Power and Manual MPS Maxx and Mini Maxx Modular AVIVA® FX (U.S.) and Kuschall® Power Standing System AVIVA RX (Europe) Power Wheelchairs Custom Manual Wheelchairs ▪ Innovative center-wheel drive ▪ Advanced seating and positioning ▪ Uniq
Slide 18: Mobility & Seating – Electromotive Power Add-On Technology
Mobility & Seating – Electromotive Power Add-On Technology Applying power add-on technology to new products, including recreational mobility devices and extension apps I N VA C A R E C O R P O R AT I O N E-Bike Drive Systems Power Hand bike Power Assist Power Assist ▪ Dynamic market growth ▪ Electri
Slide 19: Lifestyle – Beds and Safe Patient Handling
Lifestyle – Beds and Safe Patient Handling For home healthcare and long-term care settings I N VA C A R E C O R P O R AT I O N Invacare Corporation Presentation – May 23, 2022
Slide 20: Respiratory – Stationary and Ambulatory
Respiratory – Stationary and Ambulatory ▪ Launched new 5-liter stationary I N VA C A R E C O R P O R AT I O N oxygen concentrator in mid- 2021 ▪ Realized increased sales and elevated backlog of respiratory products driven by the pandemic ▪ First wirelessly remote- controlled portable oxygen concentr
Slide 21: Appendix
I N VA C A R E C O R P O R AT I O N Appendix Invacare Corporation Presentation – May 23, 2022
Slide 22: Highly Engaged and Diversified Board of Directors
Highly Engaged and Diversified Board of Directors Governance, insight and strong industry experience to guide Invacare and represent shareholders’ interests I N VA C A R E C O R P O R AT I O N Clifford D. Nastas Susan H. Julie A. Petra Danielsohn- Stephanie Marc M. Matthew E. Aron (Lead Independent
Slide 23: Experienced Management Team
Experienced Management Team Motivated team with years of international and healthcare industry experience I N VA C A R E C O R P O R AT I O N Executive Management Executive Management Business Leaders Matt Monaghan Anthony LaPlaca Geoff Purtill Chairman, President and Chief SVP, General Counsel, Chi